Medtronic, Inc. Endurant® II AAA Stent Graft System Launches Internationally with CE Mark

Published: Jan 17, 2012

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant® II AAA Stent Graft System, which meaningfully expands the options physicians outside the United States have to treat patients with abdominal aortic aneurysms through a minimally invasive technique called endovascular aortic repair (EVAR).

Back to news